EDGAR Filing Documents for 0001127602-17-003387

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001127602-17-003387

Filing Date

2017-02-01

Accepted

2017-02-01 17:21:48

Documents

Period of Report

2017-02-01

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	form4.html	4
1	PRIMARY DOCUMENT	form4.xml	4	3367
	Complete submission text file	0001127602-17-003387.txt		5205

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142

Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000

BIOGEN INC. (Reporting) CIK: 0000875045 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37859 | Film No.: 17565872
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 225 2ND AVENUE WALTHAM MA 02451

Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400

Bioverativ Inc. (Issuer) CIK: 0001681689 (see all company filings)

IRS No.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations